José Luis Castro appointed as WHO Director-General Special Envoy for chronic respiratory diseases
Castro is completing his tenure as President and CEO of Vital Strategies, a global health organisation he founded and led for 20 years

Castro is completing his tenure as President and CEO of Vital Strategies, a global health organisation he founded and led for 20 years
Google parent Alphabet Inc has appointed Anat Ashkenazi as its new Chief Financial Officer. Ashkenazi steps into the role previously held by Ruth Porat, who is transitioning to become Alphabet’s investment chief—a position announced in July 2023. She comes with over two-decades of experience at drugmaker Eli Lilly.
Anand brings a wealth of strategic insights and operational expertise to his new role in enhancing service quality and patient experience across all hospitals of Paras Health. The organisation aims to leverage Anand's experience in building a sustainable business model from hospitality to healthcare.
John Hopkins Bloomberg School of Public Health acknowledges Dr Ella’s pioneering work, remarkable influence, and determination to develop an indigenous, innovative, and safe vaccine focused on global public health. This is the school’s highest honour, reserved for outstanding public health researchers and practitioners who demonstrate exceptional leadership in safeguarding and improving public health.
Annapurna comes with more than 20 years of experience in the pharmaceutical and biotechnology industry across India and Southeast Asia.
The scientist-entrepreneur is regarded as the father of Genome Valley, and known for his pioneering work in biotechnology and will succeed Adar C Poonawala who held the post from 2019 to 2024.
Ghosh will advise on critical business strategies, including go-to-market initiatives, brand management, investor relations, and talent management, among others alongside the leadership team. He will take an instrumental role in directing Heartnet India to accomplish its mission of reaching a target of 10,000 care points within the next 24 months, making cardiac care accessible and affordable across India.
Dr Alka Malhotra, Outgoing President, IMA, South Delhi Branch will officially pass on the mantle to Dr Sabharwal, who has exhibited exemplary dedication and leadership in the field of medicine. His vision and commitment to the healthcare community make him the ideal candidate to lead the South Delhi Branch of IMA into a new era of progress and excellence.
In his role as the Managing Director, Singh will be responsible for driving the Life Science strategy in India, ensuring governance and compliance alongside other leaders from Merck's businesses in India. Singh joined Sigma-Aldrich in 1997. Over the years he took on several leadership roles in commercial organisations before he was appointed Head of Science & Lab Solutions Commercial for India, a position he held since 2022.
Joining Soi in the new leadership team are Ameera Shah, Promoter & MD, Metropolis Healthcare, as Senior Vice President, and Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, as Vice President. Dr Om Prakash Manchanda, Managing Director, Dr Lal PathLabs, is the Treasurer and Anish Bafna, CEO & MD, Healthium Medtech, is the Secretary.
Kejriwal has over 30 years of experience in private equity investments and is currently the founder and Managing Partner of Kedaara Capital